See more : CoinSmart Financial Inc. (CONMF) Income Statement Analysis – Financial Results
Complete financial analysis of Sharda Cropchem Limited (SHARDACROP.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sharda Cropchem Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Five-Star Business Finance Limited (FIVESTAR.BO) Income Statement Analysis – Financial Results
- Grade Upon Technology Corp (6739.TWO) Income Statement Analysis – Financial Results
- Rotam Global AgroSciences Limited (4141.TW) Income Statement Analysis – Financial Results
- Neuren Pharmaceuticals Limited (NEU.AX) Income Statement Analysis – Financial Results
- Essar Securities Limited (ESSARSEC.BO) Income Statement Analysis – Financial Results
Sharda Cropchem Limited (SHARDACROP.NS)
About Sharda Cropchem Limited
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts for use in mining projects, steel plants, quarries, grain silos, cement manufacturing facilities, ports, tunneling projects, etc. In addition, it offers organic and inorganic chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. The company was founded in 1987 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.61B | 40.45B | 35.76B | 23.91B | 19.98B | 19.96B | 17.07B | 13.90B | 12.19B | 10.61B | 7.90B | 7.78B |
| Cost of Revenue | 23.42B | 28.61B | 25.00B | 16.36B | 13.89B | 13.88B | 11.44B | 8.97B | 7.92B | 7.10B | 5.14B | 5.44B |
| Gross Profit | 8.18B | 11.84B | 10.76B | 7.55B | 6.09B | 6.08B | 5.63B | 4.93B | 4.26B | 3.51B | 2.76B | 2.34B |
| Gross Profit Ratio | 25.89% | 29.28% | 30.09% | 31.59% | 30.50% | 30.47% | 32.99% | 35.46% | 34.98% | 33.08% | 34.96% | 30.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.88B | 2.31B | 1.79B | 1.65B | 1.18B | 1.11B | 849.57M | 730.37M | 542.66M | 516.02M | 430.04M | 0.00 |
| Selling & Marketing | 1.00B | 1.05B | 713.81M | 516.64M | 417.65M | 405.95M | 474.08M | 454.62M | 384.92M | 409.27M | 325.17M | 0.00 |
| SG&A | 3.88B | 3.36B | 2.51B | 2.17B | 1.60B | 1.51B | 1.32B | 1.18B | 927.59M | 925.29M | 755.22M | 135.85M |
| Other Expenses | 4.30B | 402.81M | 12.61M | 22.78M | 25.84M | 92.70M | 37.61M | 14.50M | 28.20M | 33.21M | 11.15M | 0.00 |
| Operating Expenses | 8.18B | 7.32B | 5.64B | 4.27B | 3.57B | 3.22B | 2.65B | 2.25B | 1.84B | 1.71B | 1.42B | 1.18B |
| Cost & Expenses | 24.02B | 35.93B | 30.64B | 20.63B | 17.46B | 17.09B | 14.09B | 11.22B | 9.76B | 8.81B | 6.57B | 6.62B |
| Interest Income | 135.75M | 49.03M | 64.54M | 85.10M | 80.93M | 40.52M | 17.03M | 40.39M | 15.52M | 16.72M | 7.60M | 19.36M |
| Interest Expense | 241.55M | 45.10M | 22.13M | 18.16M | 19.17M | 83.92M | 48.52M | 477.00K | 261.00K | 7.28M | 13.68M | 0.00 |
| Depreciation & Amortization | 2.67B | 2.48B | 2.45B | 1.70B | 1.37B | 993.94M | 699.39M | 562.59M | 350.53M | 233.12M | 289.29M | 367.32M |
| EBITDA | 3.43B | 6.99B | 7.25B | 4.96B | 3.38B | 3.54B | 3.71B | 3.37B | 3.04B | 2.08B | 1.94B | 1.54B |
| EBITDA Ratio | 10.84% | 16.89% | 20.57% | 21.54% | 18.60% | 19.19% | 21.76% | 23.08% | 23.24% | 17.12% | 22.58% | 18.04% |
| Operating Income | 7.61B | 4.78B | 4.84B | 2.88B | 2.14B | 2.70B | 2.98B | 2.68B | 2.43B | 1.80B | 1.34B | 1.04B |
| Operating Income Ratio | 24.09% | 11.82% | 13.53% | 12.04% | 10.69% | 13.51% | 17.45% | 19.29% | 19.90% | 16.95% | 16.94% | 13.32% |
| Total Other Income/Expenses | -6.89B | -6.98B | -5.66B | -4.08B | -673.77M | -546.30M | -106.34M | 35.38M | 142.49M | -39.74M | -96.25M | 135.25M |
| Income Before Tax | 718.72M | 4.31B | 4.64B | 3.09B | 1.85B | 2.35B | 2.87B | 2.72B | 2.59B | 1.76B | 1.57B | 1.18B |
| Income Before Tax Ratio | 2.27% | 10.65% | 12.98% | 12.94% | 9.25% | 11.78% | 16.83% | 19.55% | 21.26% | 16.57% | 19.84% | 15.14% |
| Income Tax Expense | 399.65M | 887.62M | 1.15B | 802.37M | 201.78M | 586.82M | 964.16M | 813.87M | 834.96M | 524.34M | 443.19M | 334.44M |
| Net Income | 318.83M | 3.42B | 3.49B | 2.29B | 1.65B | 1.76B | 1.91B | 1.90B | 1.75B | 1.23B | 1.11B | 843.73M |
| Net Income Ratio | 1.01% | 8.45% | 9.77% | 9.58% | 8.24% | 8.84% | 11.18% | 13.70% | 14.36% | 11.59% | 14.05% | 10.84% |
| EPS | 3.53 | 37.90 | 38.71 | 25.40 | 18.25 | 19.55 | 21.14 | 21.11 | 19.41 | 13.63 | 12.31 | 9.35 |
| EPS Diluted | 3.53 | 37.90 | 38.71 | 25.40 | 18.25 | 19.55 | 21.14 | 21.11 | 19.41 | 13.63 | 12.31 | 9.35 |
| Weighted Avg Shares Out | 90.32M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.21M | 90.24M |
| Weighted Avg Shares Out (Dil) | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.22M | 90.21M | 90.22M |
Source: https://incomestatements.info
Category: Stock Reports